Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 398 participants.
Also called NCT01687166
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 398 participants
- Sponsor
- Registry
-
NCT01687166
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Czechia, France, Germany, Portugal, Spain, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01687166. Randomized; single masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2016-10 (actual). Results posted on 2018-06-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
- Acronym
- ZERO-AF
- Condition
- Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Device)
- Blazer Open-Irrigated Ablation Catheter (Boston Scientific)
- Intervention (Device)
- FDA Approved Open-Irrigated Ablation Catheter
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01687166- Content hash
b5d2753be31e3674a9836eccd8d5c47075fc65f7afeba2bcae26d3f7de55a0ed